Tumour necrosis factor-α potentiates contraction of human bronchus in vitro
- Publication Type:
- Journal Article
- Respirology, 2001, 6 (3), pp. 199 - 203
- Issue Date:
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Objective: Chronic inflammation of the airways is an important component in the induction of airway hyperresponsiveness (AHR) in asthma. The pro-inflammatory cytokines interleukin-1β (IL-1β) and tumour necrosis factor-cc (TNF-α) have been implicated in the induction of AHR. Whether these cytokines directly modulate the contractile properties of human airway smooth muscle (ASM) has not been fully investigated. Methodology: The contractile response to acetylcholine (ACh) (10-8 to 10-3 mol/L) was determined in isolated human bronchial segments both prior to and following a 16-h incubation period with IL-1β (10 or 20 ng/mL) and TNF-α (25 ng/mL), either alone or in combination. Incubation of human bronchial segments with IL-1β/TNF-α was also performed in the presence of the COX-1/COX-2 inhibitor, indomethacin. Results: Tumour necrosis factor-α potentiated the contractile response to ACh by approximately 27%, while IL-1β or the cytokines in combination had no effect. Indomethacin had no modulatory effect on the contractile response to ACh in the cytokine-treated tissues. Conclusions: The relative concentrations of IL-1β/TNF-α in the vicinity of ASM may ultimately determine their effects on ASM contraction in asthma.
Please use this identifier to cite or link to this item: